Cargando…
Engineering strategies to enhance oncolytic viruses in cancer immunotherapy
Oncolytic viruses (OVs) are emerging as potentially useful platforms in treatment methods for patients with tumors. They preferentially target and kill tumor cells, leaving healthy cells unharmed. In addition to direct oncolysis, the essential and attractive aspect of oncolytic virotherapy is based...
Autores principales: | Tian, Yaomei, Xie, Daoyuan, Yang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987060/ https://www.ncbi.nlm.nih.gov/pubmed/35387984 http://dx.doi.org/10.1038/s41392-022-00951-x |
Ejemplares similares
-
Oncolytic Virus Engineering and Utilizations: Cancer Immunotherapy Perspective
por: Muthukutty, Palaniyandi, et al.
Publicado: (2023) -
Oncolytic viruses for cancer immunotherapy
por: Hemminki, Otto, et al.
Publicado: (2020) -
Oncolytic adenoviruses expressing checkpoint inhibitors for cancer therapy
por: Xie, Daoyuan, et al.
Publicado: (2023) -
Oncolytic Viruses—Natural and Genetically Engineered Cancer Immunotherapies
por: Jhawar, Sachin R., et al.
Publicado: (2017) -
Capitalizing on Cancer Specific Replication: Oncolytic Viruses as a Versatile Platform for the Enhancement of Cancer Immunotherapy Strategies
por: Bastin, Donald, et al.
Publicado: (2016)